Other applications for our compounds

The main focus of SUL-138 is the prevention of Acute Kidney Injury (AKI) during cardiac surgery. But besides AKI SUL-138 also has multiple applications in other therapeutic areas such as:

Investment opportunities

Sulfateq consist of an experienced and dedicated team. On board are internationally known clinicians who work for the University Medical Hospital clinic (UMCG Groningen) and who have extensive experience with clinical trials, especially in kidney diseases. Due to the rapid expansion of the company and developments in the markets we are currently looking  for new investors or funding opportunities to develop and expand further business. Are you interested in investing in a breakthrough solution for the prevention of Acute Kidney Injury? Click here for more information!